Fig. 4
From: Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses
Supernatant from PBMCs cultured with Dengue virus increases surface receptors for Dengue virus cell binding and entry as well as immune checkpoint inhibition on tumor cells. A Flow plot analysis of MDA-MB-231 tumor cells by flow cytometry for expression of Dengue virus receptor ligands, DC-SIGN and Syndecan-1, as well as immune checkpoint receptor, PD-L1. B Fold change of receptors comparing levels from the PV001-DV supernatant treatment (DV sup) over media control (Control sup)